Amylyx drug comes up short; Sanofi names new CMO
Written by
BioPharma Dive
Published
0
comments
0
min
AMX0035 missed the goals of a study in progressive supranuclear palsy. Elsewhere, Novartis and BioArctic struck a deal, and Genentech started building its first East Coast factory.